Global Complement Drug Market Research Report 2023
This report aims to provide a comprehensive presentation of the global market for Complement Drug, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Complement Drug.
The Complement Drug market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2022 as the base year, with history and forecast data for the period from 2018 to 2029. This report segments the global Complement Drug market comprehensively. Regional market sizes, concerning products by type, by application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Complement Drug companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by type, by application, and by regions.
By Company
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Complement Drug companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the key companies in the market in detail, including product revenue, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
The Complement Drug market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2022 as the base year, with history and forecast data for the period from 2018 to 2029. This report segments the global Complement Drug market comprehensively. Regional market sizes, concerning products by type, by application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Complement Drug companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by type, by application, and by regions.
By Company
- Novartis AG
- Alexion Pharmaceuticals
- ChemoCentryx
- Roche
- Apellis
- Regeneron
- Amgen
- Alnylam
- UCB
- InflaRx
- ChemoCentryx
- Innate Pharma
- Ionis Pharmaceuticals
- Avant Immunotherapeutics
- Pfizer
- Sanofi
- Omeros
- GenMab
- Akari Therapeutics
- AbbVie
- Peptides
- Antibodies
- Others
- Blood Disease
- Kidney Disease
- Others
- North America
- United States
- Canada
- Europe
- Germany
- France
- UK
- Italy
- Russia
- Nordic Countries
- Rest of Europe
- Asia-Pacific
- China
- Japan
- South Korea
- Southeast Asia
- India
- Australia
- Rest of Asia
- Latin America
- Mexico
- Brazil
- Rest of Latin America
- Middle East & Africa
- Turkey
- Saudi Arabia
- UAE
- Rest of MEA
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Complement Drug companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the key companies in the market in detail, including product revenue, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
1 STUDY COVERAGE
1.1 3D Hydrogels in Cell Culture Product Introduction
1.2 Market by Type
1.2.1 Global 3D Hydrogels in Cell Culture Market Size Growth Rate by Type, 2018 VS 2022 VS 2029
1.2.2 Scaffold Free
1.2.3 Scaffold Based
1.3 Market by Application
1.3.1 Global 3D Hydrogels in Cell Culture Market Size Growth Rate by Application, 2018 VS 2022 VS 2029
1.3.2 Research Laboratories and Institutes
1.3.3 Diagnostic Centers
1.3.4 Biotechnology and Pharmaceutical Industries
1.3.5 Others
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 EXECUTIVE SUMMARY
2.1 Global 3D Hydrogels in Cell Culture Sales Estimates and Forecasts 2018-2029
2.2 Global 3D Hydrogels in Cell Culture Revenue by Region
2.2.1 Global 3D Hydrogels in Cell Culture Revenue by Region: 2018 VS 2022 VS 2029
2.2.2 Global 3D Hydrogels in Cell Culture Revenue by Region (2018-2023)
2.2.3 Global 3D Hydrogels in Cell Culture Revenue by Region (2024-2029)
2.2.4 Global 3D Hydrogels in Cell Culture Revenue Market Share by Region (2018-2029)
2.3 Global 3D Hydrogels in Cell Culture Sales Estimates and Forecasts 2018-2029
2.4 Global 3D Hydrogels in Cell Culture Sales by Region
2.4.1 Global 3D Hydrogels in Cell Culture Sales by Region: 2018 VS 2022 VS 2029
2.4.2 Global 3D Hydrogels in Cell Culture Sales by Region (2018-2023)
2.4.3 Global 3D Hydrogels in Cell Culture Sales by Region (2024-2029)
2.4.4 Global 3D Hydrogels in Cell Culture Sales Market Share by Region (2018-2029)
2.5 US & Canada
2.6 Europe
2.7 China
2.8 Asia (excluding China)
2.9 Middle East, Africa and Latin America
3 COMPETITION BY MANUFACTURES
3.1 Global 3D Hydrogels in Cell Culture Sales by Manufacturers
3.1.1 Global 3D Hydrogels in Cell Culture Sales by Manufacturers (2018-2023)
3.1.2 Global 3D Hydrogels in Cell Culture Sales Market Share by Manufacturers (2018-2023)
3.1.3 Global Top 10 and Top 5 Largest Manufacturers of 3D Hydrogels in Cell Culture in 2022
3.2 Global 3D Hydrogels in Cell Culture Revenue by Manufacturers
3.2.1 Global 3D Hydrogels in Cell Culture Revenue by Manufacturers (2018-2023)
3.2.2 Global 3D Hydrogels in Cell Culture Revenue Market Share by Manufacturers (2018-2023)
3.2.3 Global Top 10 and Top 5 Companies by 3D Hydrogels in Cell Culture Revenue in 2022
3.3 Global Key Players of 3D Hydrogels in Cell Culture, Industry Ranking, 2021 VS 2022 VS 2023
3.4 Global 3D Hydrogels in Cell Culture Sales Price by Manufacturers
3.5 Analysis of Competitive Landscape
3.5.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
3.5.2 Global 3D Hydrogels in Cell Culture Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.6 Global Key Manufacturers of 3D Hydrogels in Cell Culture, Manufacturing Base Distribution and Headquarters
3.7 Global Key Manufacturers of 3D Hydrogels in Cell Culture, Product Offered and Application
3.8 Global Key Manufacturers of 3D Hydrogels in Cell Culture, Date of Enter into This Industry
3.9 Mergers & Acquisitions, Expansion Plans
4 MARKET SIZE BY TYPE
4.1 Global 3D Hydrogels in Cell Culture Sales by Type
4.1.1 Global 3D Hydrogels in Cell Culture Historical Sales by Type (2018-2023)
4.1.2 Global 3D Hydrogels in Cell Culture Forecasted Sales by Type (2024-2029)
4.1.3 Global 3D Hydrogels in Cell Culture Sales Market Share by Type (2018-2029)
4.2 Global 3D Hydrogels in Cell Culture Revenue by Type
4.2.1 Global 3D Hydrogels in Cell Culture Historical Revenue by Type (2018-2023)
4.2.2 Global 3D Hydrogels in Cell Culture Forecasted Revenue by Type (2024-2029)
4.2.3 Global 3D Hydrogels in Cell Culture Revenue Market Share by Type (2018-2029)
4.3 Global 3D Hydrogels in Cell Culture Price by Type
4.3.1 Global 3D Hydrogels in Cell Culture Price by Type (2018-2023)
4.3.2 Global 3D Hydrogels in Cell Culture Price Forecast by Type (2024-2029)
5 MARKET SIZE BY APPLICATION
5.1 Global 3D Hydrogels in Cell Culture Sales by Application
5.1.1 Global 3D Hydrogels in Cell Culture Historical Sales by Application (2018-2023)
5.1.2 Global 3D Hydrogels in Cell Culture Forecasted Sales by Application (2024-2029)
5.1.3 Global 3D Hydrogels in Cell Culture Sales Market Share by Application (2018-2029)
5.2 Global 3D Hydrogels in Cell Culture Revenue by Application
5.2.1 Global 3D Hydrogels in Cell Culture Historical Revenue by Application (2018-2023)
5.2.2 Global 3D Hydrogels in Cell Culture Forecasted Revenue by Application (2024-2029)
5.2.3 Global 3D Hydrogels in Cell Culture Revenue Market Share by Application (2018-2029)
5.3 Global 3D Hydrogels in Cell Culture Price by Application
5.3.1 Global 3D Hydrogels in Cell Culture Price by Application (2018-2023)
5.3.2 Global 3D Hydrogels in Cell Culture Price Forecast by Application (2024-2029)
6 US & CANADA
6.1 US & Canada 3D Hydrogels in Cell Culture Market Size by Type
6.1.1 US & Canada 3D Hydrogels in Cell Culture Sales by Type (2018-2029)
6.1.2 US & Canada 3D Hydrogels in Cell Culture Revenue by Type (2018-2029)
6.2 US & Canada 3D Hydrogels in Cell Culture Market Size by Application
6.2.1 US & Canada 3D Hydrogels in Cell Culture Sales by Application (2018-2029)
6.2.2 US & Canada 3D Hydrogels in Cell Culture Revenue by Application (2018-2029)
6.3 US & Canada 3D Hydrogels in Cell Culture Market Size by Country
6.3.1 US & Canada 3D Hydrogels in Cell Culture Revenue by Country: 2018 VS 2022 VS 2029
6.3.2 US & Canada 3D Hydrogels in Cell Culture Sales by Country (2018-2029)
6.3.3 US & Canada 3D Hydrogels in Cell Culture Revenue by Country (2018-2029)
6.3.4 US
6.3.5 Canada
7 EUROPE
7.1 Europe 3D Hydrogels in Cell Culture Market Size by Type
7.1.1 Europe 3D Hydrogels in Cell Culture Sales by Type (2018-2029)
7.1.2 Europe 3D Hydrogels in Cell Culture Revenue by Type (2018-2029)
7.2 Europe 3D Hydrogels in Cell Culture Market Size by Application
7.2.1 Europe 3D Hydrogels in Cell Culture Sales by Application (2018-2029)
7.2.2 Europe 3D Hydrogels in Cell Culture Revenue by Application (2018-2029)
7.3 Europe 3D Hydrogels in Cell Culture Market Size by Country
7.3.1 Europe 3D Hydrogels in Cell Culture Revenue by Country: 2018 VS 2022 VS 2029
7.3.2 Europe 3D Hydrogels in Cell Culture Sales by Country (2018-2029)
7.3.3 Europe 3D Hydrogels in Cell Culture Revenue by Country (2018-2029)
7.3.4 Germany
7.3.5 France
7.3.6 U.K.
7.3.7 Italy
7.3.8 Russia
8 CHINA
8.1 China 3D Hydrogels in Cell Culture Market Size
8.1.1 China 3D Hydrogels in Cell Culture Sales (2018-2029)
8.1.2 China 3D Hydrogels in Cell Culture Revenue (2018-2029)
8.2 China 3D Hydrogels in Cell Culture Market Size by Application
8.2.1 China 3D Hydrogels in Cell Culture Sales by Application (2018-2029)
8.2.2 China 3D Hydrogels in Cell Culture Revenue by Application (2018-2029)
9 ASIA (EXCLUDING CHINA)
9.1 Asia 3D Hydrogels in Cell Culture Market Size by Type
9.1.1 Asia 3D Hydrogels in Cell Culture Sales by Type (2018-2029)
9.1.2 Asia 3D Hydrogels in Cell Culture Revenue by Type (2018-2029)
9.2 Asia 3D Hydrogels in Cell Culture Market Size by Application
9.2.1 Asia 3D Hydrogels in Cell Culture Sales by Application (2018-2029)
9.2.2 Asia 3D Hydrogels in Cell Culture Revenue by Application (2018-2029)
9.3 Asia 3D Hydrogels in Cell Culture Sales by Region
9.3.1 Asia 3D Hydrogels in Cell Culture Revenue by Region: 2018 VS 2022 VS 2029
9.3.2 Asia 3D Hydrogels in Cell Culture Revenue by Region (2018-2029)
9.3.3 Asia 3D Hydrogels in Cell Culture Sales by Region (2018-2029)
9.3.4 Japan
9.3.5 South Korea
9.3.6 China Taiwan
9.3.7 Southeast Asia
9.3.8 India
10 MIDDLE EAST, AFRICA AND LATIN AMERICA
10.1 Middle East, Africa and Latin America 3D Hydrogels in Cell Culture Market Size by Type
10.1.1 Middle East, Africa and Latin America 3D Hydrogels in Cell Culture Sales by Type (2018-2029)
10.1.2 Middle East, Africa and Latin America 3D Hydrogels in Cell Culture Revenue by Type (2018-2029)
10.2 Middle East, Africa and Latin America 3D Hydrogels in Cell Culture Market Size by Application
10.2.1 Middle East, Africa and Latin America 3D Hydrogels in Cell Culture Sales by Application (2018-2029)
10.2.2 Middle East, Africa and Latin America 3D Hydrogels in Cell Culture Revenue by Application (2018-2029)
10.3 Middle East, Africa and Latin America 3D Hydrogels in Cell Culture Sales by Country
10.3.1 Middle East, Africa and Latin America 3D Hydrogels in Cell Culture Revenue by Country: 2018 VS 2022 VS 2029
10.3.2 Middle East, Africa and Latin America 3D Hydrogels in Cell Culture Revenue by Country (2018-2029)
10.3.3 Middle East, Africa and Latin America 3D Hydrogels in Cell Culture Sales by Country (2018-2029)
10.3.4 Brazil
10.3.5 Mexico
10.3.6 Turkey
10.3.7 Israel
10.3.8 GCC Countries
11 COMPANY PROFILES
11.1 UPM Global
11.1.1 UPM Global Company Information
11.1.2 UPM Global Overview
11.1.3 UPM Global 3D Hydrogels in Cell Culture Sales, Price, Revenue and Gross Margin (2018-2023)
11.1.4 UPM Global 3D Hydrogels in Cell Culture Product Model Numbers, Pictures, Descriptions and Specifications
11.1.5 UPM Global Recent Developments
11.2 AMS Biotechnology (Europe) Limited
11.2.1 AMS Biotechnology (Europe) Limited Company Information
11.2.2 AMS Biotechnology (Europe) Limited Overview
11.2.3 AMS Biotechnology (Europe) Limited 3D Hydrogels in Cell Culture Sales, Price, Revenue and Gross Margin (2018-2023)
11.2.4 AMS Biotechnology (Europe) Limited 3D Hydrogels in Cell Culture Product Model Numbers, Pictures, Descriptions and Specifications
11.2.5 AMS Biotechnology (Europe) Limited Recent Developments
11.3 3D Biotek
11.3.1 3D Biotek Company Information
11.3.2 3D Biotek Overview
11.3.3 3D Biotek 3D Hydrogels in Cell Culture Sales, Price, Revenue and Gross Margin (2018-2023)
11.3.4 3D Biotek 3D Hydrogels in Cell Culture Product Model Numbers, Pictures, Descriptions and Specifications
11.3.5 3D Biotek Recent Developments
11.4 Becton
11.4.1 Becton Company Information
11.4.2 Becton Overview
11.4.3 Becton 3D Hydrogels in Cell Culture Sales, Price, Revenue and Gross Margin (2018-2023)
11.4.4 Becton 3D Hydrogels in Cell Culture Product Model Numbers, Pictures, Descriptions and Specifications
11.4.5 Becton Recent Developments
11.5 Dickinson and Company
11.5.1 Dickinson and Company Company Information
11.5.2 Dickinson and Company Overview
11.5.3 Dickinson and Company 3D Hydrogels in Cell Culture Sales, Price, Revenue and Gross Margin (2018-2023)
11.5.4 Dickinson and Company 3D Hydrogels in Cell Culture Product Model Numbers, Pictures, Descriptions and Specifications
11.5.5 Dickinson and Company Recent Developments
11.6 Corning
11.6.1 Corning Company Information
11.6.2 Corning Overview
11.6.3 Corning 3D Hydrogels in Cell Culture Sales, Price, Revenue and Gross Margin (2018-2023)
11.6.4 Corning 3D Hydrogels in Cell Culture Product Model Numbers, Pictures, Descriptions and Specifications
11.6.5 Corning Recent Developments
11.7 Global Cell Solutions
11.7.1 Global Cell Solutions Company Information
11.7.2 Global Cell Solutions Overview
11.7.3 Global Cell Solutions 3D Hydrogels in Cell Culture Sales, Price, Revenue and Gross Margin (2018-2023)
11.7.4 Global Cell Solutions 3D Hydrogels in Cell Culture Product Model Numbers, Pictures, Descriptions and Specifications
11.7.5 Global Cell Solutions Recent Developments
11.8 InSphero
11.8.1 InSphero Company Information
11.8.2 InSphero Overview
11.8.3 InSphero 3D Hydrogels in Cell Culture Sales, Price, Revenue and Gross Margin (2018-2023)
11.8.4 InSphero 3D Hydrogels in Cell Culture Product Model Numbers, Pictures, Descriptions and Specifications
11.8.5 InSphero Recent Developments
11.9 Lonza Group
11.9.1 Lonza Group Company Information
11.9.2 Lonza Group Overview
11.9.3 Lonza Group 3D Hydrogels in Cell Culture Sales, Price, Revenue and Gross Margin (2018-2023)
11.9.4 Lonza Group 3D Hydrogels in Cell Culture Product Model Numbers, Pictures, Descriptions and Specifications
11.9.5 Lonza Group Recent Developments
11.10 Nanofiber Solutions
11.10.1 Nanofiber Solutions Company Information
11.10.2 Nanofiber Solutions Overview
11.10.3 Nanofiber Solutions 3D Hydrogels in Cell Culture Sales, Price, Revenue and Gross Margin (2018-2023)
11.10.4 Nanofiber Solutions 3D Hydrogels in Cell Culture Product Model Numbers, Pictures, Descriptions and Specifications
11.10.5 Nanofiber Solutions Recent Developments
11.11 Boca Scientific
11.11.1 Boca Scientific Company Information
11.11.2 Boca Scientific Overview
11.11.3 Boca Scientific 3D Hydrogels in Cell Culture Sales, Price, Revenue and Gross Margin (2018-2023)
11.11.4 Boca Scientific 3D Hydrogels in Cell Culture Product Model Numbers, Pictures, Descriptions and Specifications
11.11.5 Boca Scientific Recent Developments
11.12 Esi Bio
11.12.1 Esi Bio Company Information
11.12.2 Esi Bio Overview
11.12.3 Esi Bio 3D Hydrogels in Cell Culture Sales, Price, Revenue and Gross Margin (2018-2023)
11.12.4 Esi Bio 3D Hydrogels in Cell Culture Product Model Numbers, Pictures, Descriptions and Specifications
11.12.5 Esi Bio Recent Developments
11.13 Sigma-Aldrich Corp
11.13.1 Sigma-Aldrich Corp Company Information
11.13.2 Sigma-Aldrich Corp Overview
11.13.3 Sigma-Aldrich Corp 3D Hydrogels in Cell Culture Sales, Price, Revenue and Gross Margin (2018-2023)
11.13.4 Sigma-Aldrich Corp 3D Hydrogels in Cell Culture Product Model Numbers, Pictures, Descriptions and Specifications
11.13.5 Sigma-Aldrich Corp Recent Developments
11.14 Ferentis
11.14.1 Ferentis Company Information
11.14.2 Ferentis Overview
11.14.3 Ferentis 3D Hydrogels in Cell Culture Sales, Price, Revenue and Gross Margin (2018-2023)
11.14.4 Ferentis 3D Hydrogels in Cell Culture Product Model Numbers, Pictures, Descriptions and Specifications
11.14.5 Ferentis Recent Developments
11.15 Tecan Trading
11.15.1 Tecan Trading Company Information
11.15.2 Tecan Trading Overview
11.15.3 Tecan Trading 3D Hydrogels in Cell Culture Sales, Price, Revenue and Gross Margin (2018-2023)
11.15.4 Tecan Trading 3D Hydrogels in Cell Culture Product Model Numbers, Pictures, Descriptions and Specifications
11.15.5 Tecan Trading Recent Developments
11.16 Cellendes
11.16.1 Cellendes Company Information
11.16.2 Cellendes Overview
11.16.3 Cellendes 3D Hydrogels in Cell Culture Sales, Price, Revenue and Gross Margin (2018-2023)
11.16.4 Cellendes 3D Hydrogels in Cell Culture Product Model Numbers, Pictures, Descriptions and Specifications
11.16.5 Cellendes Recent Developments
11.17 Cosmo Bio USA
11.17.1 Cosmo Bio USA Company Information
11.17.2 Cosmo Bio USA Overview
11.17.3 Cosmo Bio USA 3D Hydrogels in Cell Culture Sales, Price, Revenue and Gross Margin (2018-2023)
11.17.4 Cosmo Bio USA 3D Hydrogels in Cell Culture Product Model Numbers, Pictures, Descriptions and Specifications
11.17.5 Cosmo Bio USA Recent Developments
11.18 Thermo Fisher Scientific
11.18.1 Thermo Fisher Scientific Company Information
11.18.2 Thermo Fisher Scientific Overview
11.18.3 Thermo Fisher Scientific 3D Hydrogels in Cell Culture Sales, Price, Revenue and Gross Margin (2018-2023)
11.18.4 Thermo Fisher Scientific 3D Hydrogels in Cell Culture Product Model Numbers, Pictures, Descriptions and Specifications
11.18.5 Thermo Fisher Scientific Recent Developments
12 INDUSTRY CHAIN AND SALES CHANNELS ANALYSIS
12.1 3D Hydrogels in Cell Culture Industry Chain Analysis
12.2 3D Hydrogels in Cell Culture Key Raw Materials
12.2.1 Key Raw Materials
12.2.2 Raw Materials Key Suppliers
12.3 3D Hydrogels in Cell Culture Production Mode & Process
12.4 3D Hydrogels in Cell Culture Sales and Marketing
12.4.1 3D Hydrogels in Cell Culture Sales Channels
12.4.2 3D Hydrogels in Cell Culture Distributors
12.5 3D Hydrogels in Cell Culture Customers
13 MARKET DYNAMICS
13.1 3D Hydrogels in Cell Culture Industry Trends
13.2 3D Hydrogels in Cell Culture Market Drivers
13.3 3D Hydrogels in Cell Culture Market Challenges
13.4 3D Hydrogels in Cell Culture Market Restraints
14 KEY FINDINGS IN THE GLOBAL 3D HYDROGELS IN CELL CULTURE STUDY
15 APPENDIX
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Author Details
15.3 Disclaimer
1.1 3D Hydrogels in Cell Culture Product Introduction
1.2 Market by Type
1.2.1 Global 3D Hydrogels in Cell Culture Market Size Growth Rate by Type, 2018 VS 2022 VS 2029
1.2.2 Scaffold Free
1.2.3 Scaffold Based
1.3 Market by Application
1.3.1 Global 3D Hydrogels in Cell Culture Market Size Growth Rate by Application, 2018 VS 2022 VS 2029
1.3.2 Research Laboratories and Institutes
1.3.3 Diagnostic Centers
1.3.4 Biotechnology and Pharmaceutical Industries
1.3.5 Others
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 EXECUTIVE SUMMARY
2.1 Global 3D Hydrogels in Cell Culture Sales Estimates and Forecasts 2018-2029
2.2 Global 3D Hydrogels in Cell Culture Revenue by Region
2.2.1 Global 3D Hydrogels in Cell Culture Revenue by Region: 2018 VS 2022 VS 2029
2.2.2 Global 3D Hydrogels in Cell Culture Revenue by Region (2018-2023)
2.2.3 Global 3D Hydrogels in Cell Culture Revenue by Region (2024-2029)
2.2.4 Global 3D Hydrogels in Cell Culture Revenue Market Share by Region (2018-2029)
2.3 Global 3D Hydrogels in Cell Culture Sales Estimates and Forecasts 2018-2029
2.4 Global 3D Hydrogels in Cell Culture Sales by Region
2.4.1 Global 3D Hydrogels in Cell Culture Sales by Region: 2018 VS 2022 VS 2029
2.4.2 Global 3D Hydrogels in Cell Culture Sales by Region (2018-2023)
2.4.3 Global 3D Hydrogels in Cell Culture Sales by Region (2024-2029)
2.4.4 Global 3D Hydrogels in Cell Culture Sales Market Share by Region (2018-2029)
2.5 US & Canada
2.6 Europe
2.7 China
2.8 Asia (excluding China)
2.9 Middle East, Africa and Latin America
3 COMPETITION BY MANUFACTURES
3.1 Global 3D Hydrogels in Cell Culture Sales by Manufacturers
3.1.1 Global 3D Hydrogels in Cell Culture Sales by Manufacturers (2018-2023)
3.1.2 Global 3D Hydrogels in Cell Culture Sales Market Share by Manufacturers (2018-2023)
3.1.3 Global Top 10 and Top 5 Largest Manufacturers of 3D Hydrogels in Cell Culture in 2022
3.2 Global 3D Hydrogels in Cell Culture Revenue by Manufacturers
3.2.1 Global 3D Hydrogels in Cell Culture Revenue by Manufacturers (2018-2023)
3.2.2 Global 3D Hydrogels in Cell Culture Revenue Market Share by Manufacturers (2018-2023)
3.2.3 Global Top 10 and Top 5 Companies by 3D Hydrogels in Cell Culture Revenue in 2022
3.3 Global Key Players of 3D Hydrogels in Cell Culture, Industry Ranking, 2021 VS 2022 VS 2023
3.4 Global 3D Hydrogels in Cell Culture Sales Price by Manufacturers
3.5 Analysis of Competitive Landscape
3.5.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
3.5.2 Global 3D Hydrogels in Cell Culture Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.6 Global Key Manufacturers of 3D Hydrogels in Cell Culture, Manufacturing Base Distribution and Headquarters
3.7 Global Key Manufacturers of 3D Hydrogels in Cell Culture, Product Offered and Application
3.8 Global Key Manufacturers of 3D Hydrogels in Cell Culture, Date of Enter into This Industry
3.9 Mergers & Acquisitions, Expansion Plans
4 MARKET SIZE BY TYPE
4.1 Global 3D Hydrogels in Cell Culture Sales by Type
4.1.1 Global 3D Hydrogels in Cell Culture Historical Sales by Type (2018-2023)
4.1.2 Global 3D Hydrogels in Cell Culture Forecasted Sales by Type (2024-2029)
4.1.3 Global 3D Hydrogels in Cell Culture Sales Market Share by Type (2018-2029)
4.2 Global 3D Hydrogels in Cell Culture Revenue by Type
4.2.1 Global 3D Hydrogels in Cell Culture Historical Revenue by Type (2018-2023)
4.2.2 Global 3D Hydrogels in Cell Culture Forecasted Revenue by Type (2024-2029)
4.2.3 Global 3D Hydrogels in Cell Culture Revenue Market Share by Type (2018-2029)
4.3 Global 3D Hydrogels in Cell Culture Price by Type
4.3.1 Global 3D Hydrogels in Cell Culture Price by Type (2018-2023)
4.3.2 Global 3D Hydrogels in Cell Culture Price Forecast by Type (2024-2029)
5 MARKET SIZE BY APPLICATION
5.1 Global 3D Hydrogels in Cell Culture Sales by Application
5.1.1 Global 3D Hydrogels in Cell Culture Historical Sales by Application (2018-2023)
5.1.2 Global 3D Hydrogels in Cell Culture Forecasted Sales by Application (2024-2029)
5.1.3 Global 3D Hydrogels in Cell Culture Sales Market Share by Application (2018-2029)
5.2 Global 3D Hydrogels in Cell Culture Revenue by Application
5.2.1 Global 3D Hydrogels in Cell Culture Historical Revenue by Application (2018-2023)
5.2.2 Global 3D Hydrogels in Cell Culture Forecasted Revenue by Application (2024-2029)
5.2.3 Global 3D Hydrogels in Cell Culture Revenue Market Share by Application (2018-2029)
5.3 Global 3D Hydrogels in Cell Culture Price by Application
5.3.1 Global 3D Hydrogels in Cell Culture Price by Application (2018-2023)
5.3.2 Global 3D Hydrogels in Cell Culture Price Forecast by Application (2024-2029)
6 US & CANADA
6.1 US & Canada 3D Hydrogels in Cell Culture Market Size by Type
6.1.1 US & Canada 3D Hydrogels in Cell Culture Sales by Type (2018-2029)
6.1.2 US & Canada 3D Hydrogels in Cell Culture Revenue by Type (2018-2029)
6.2 US & Canada 3D Hydrogels in Cell Culture Market Size by Application
6.2.1 US & Canada 3D Hydrogels in Cell Culture Sales by Application (2018-2029)
6.2.2 US & Canada 3D Hydrogels in Cell Culture Revenue by Application (2018-2029)
6.3 US & Canada 3D Hydrogels in Cell Culture Market Size by Country
6.3.1 US & Canada 3D Hydrogels in Cell Culture Revenue by Country: 2018 VS 2022 VS 2029
6.3.2 US & Canada 3D Hydrogels in Cell Culture Sales by Country (2018-2029)
6.3.3 US & Canada 3D Hydrogels in Cell Culture Revenue by Country (2018-2029)
6.3.4 US
6.3.5 Canada
7 EUROPE
7.1 Europe 3D Hydrogels in Cell Culture Market Size by Type
7.1.1 Europe 3D Hydrogels in Cell Culture Sales by Type (2018-2029)
7.1.2 Europe 3D Hydrogels in Cell Culture Revenue by Type (2018-2029)
7.2 Europe 3D Hydrogels in Cell Culture Market Size by Application
7.2.1 Europe 3D Hydrogels in Cell Culture Sales by Application (2018-2029)
7.2.2 Europe 3D Hydrogels in Cell Culture Revenue by Application (2018-2029)
7.3 Europe 3D Hydrogels in Cell Culture Market Size by Country
7.3.1 Europe 3D Hydrogels in Cell Culture Revenue by Country: 2018 VS 2022 VS 2029
7.3.2 Europe 3D Hydrogels in Cell Culture Sales by Country (2018-2029)
7.3.3 Europe 3D Hydrogels in Cell Culture Revenue by Country (2018-2029)
7.3.4 Germany
7.3.5 France
7.3.6 U.K.
7.3.7 Italy
7.3.8 Russia
8 CHINA
8.1 China 3D Hydrogels in Cell Culture Market Size
8.1.1 China 3D Hydrogels in Cell Culture Sales (2018-2029)
8.1.2 China 3D Hydrogels in Cell Culture Revenue (2018-2029)
8.2 China 3D Hydrogels in Cell Culture Market Size by Application
8.2.1 China 3D Hydrogels in Cell Culture Sales by Application (2018-2029)
8.2.2 China 3D Hydrogels in Cell Culture Revenue by Application (2018-2029)
9 ASIA (EXCLUDING CHINA)
9.1 Asia 3D Hydrogels in Cell Culture Market Size by Type
9.1.1 Asia 3D Hydrogels in Cell Culture Sales by Type (2018-2029)
9.1.2 Asia 3D Hydrogels in Cell Culture Revenue by Type (2018-2029)
9.2 Asia 3D Hydrogels in Cell Culture Market Size by Application
9.2.1 Asia 3D Hydrogels in Cell Culture Sales by Application (2018-2029)
9.2.2 Asia 3D Hydrogels in Cell Culture Revenue by Application (2018-2029)
9.3 Asia 3D Hydrogels in Cell Culture Sales by Region
9.3.1 Asia 3D Hydrogels in Cell Culture Revenue by Region: 2018 VS 2022 VS 2029
9.3.2 Asia 3D Hydrogels in Cell Culture Revenue by Region (2018-2029)
9.3.3 Asia 3D Hydrogels in Cell Culture Sales by Region (2018-2029)
9.3.4 Japan
9.3.5 South Korea
9.3.6 China Taiwan
9.3.7 Southeast Asia
9.3.8 India
10 MIDDLE EAST, AFRICA AND LATIN AMERICA
10.1 Middle East, Africa and Latin America 3D Hydrogels in Cell Culture Market Size by Type
10.1.1 Middle East, Africa and Latin America 3D Hydrogels in Cell Culture Sales by Type (2018-2029)
10.1.2 Middle East, Africa and Latin America 3D Hydrogels in Cell Culture Revenue by Type (2018-2029)
10.2 Middle East, Africa and Latin America 3D Hydrogels in Cell Culture Market Size by Application
10.2.1 Middle East, Africa and Latin America 3D Hydrogels in Cell Culture Sales by Application (2018-2029)
10.2.2 Middle East, Africa and Latin America 3D Hydrogels in Cell Culture Revenue by Application (2018-2029)
10.3 Middle East, Africa and Latin America 3D Hydrogels in Cell Culture Sales by Country
10.3.1 Middle East, Africa and Latin America 3D Hydrogels in Cell Culture Revenue by Country: 2018 VS 2022 VS 2029
10.3.2 Middle East, Africa and Latin America 3D Hydrogels in Cell Culture Revenue by Country (2018-2029)
10.3.3 Middle East, Africa and Latin America 3D Hydrogels in Cell Culture Sales by Country (2018-2029)
10.3.4 Brazil
10.3.5 Mexico
10.3.6 Turkey
10.3.7 Israel
10.3.8 GCC Countries
11 COMPANY PROFILES
11.1 UPM Global
11.1.1 UPM Global Company Information
11.1.2 UPM Global Overview
11.1.3 UPM Global 3D Hydrogels in Cell Culture Sales, Price, Revenue and Gross Margin (2018-2023)
11.1.4 UPM Global 3D Hydrogels in Cell Culture Product Model Numbers, Pictures, Descriptions and Specifications
11.1.5 UPM Global Recent Developments
11.2 AMS Biotechnology (Europe) Limited
11.2.1 AMS Biotechnology (Europe) Limited Company Information
11.2.2 AMS Biotechnology (Europe) Limited Overview
11.2.3 AMS Biotechnology (Europe) Limited 3D Hydrogels in Cell Culture Sales, Price, Revenue and Gross Margin (2018-2023)
11.2.4 AMS Biotechnology (Europe) Limited 3D Hydrogels in Cell Culture Product Model Numbers, Pictures, Descriptions and Specifications
11.2.5 AMS Biotechnology (Europe) Limited Recent Developments
11.3 3D Biotek
11.3.1 3D Biotek Company Information
11.3.2 3D Biotek Overview
11.3.3 3D Biotek 3D Hydrogels in Cell Culture Sales, Price, Revenue and Gross Margin (2018-2023)
11.3.4 3D Biotek 3D Hydrogels in Cell Culture Product Model Numbers, Pictures, Descriptions and Specifications
11.3.5 3D Biotek Recent Developments
11.4 Becton
11.4.1 Becton Company Information
11.4.2 Becton Overview
11.4.3 Becton 3D Hydrogels in Cell Culture Sales, Price, Revenue and Gross Margin (2018-2023)
11.4.4 Becton 3D Hydrogels in Cell Culture Product Model Numbers, Pictures, Descriptions and Specifications
11.4.5 Becton Recent Developments
11.5 Dickinson and Company
11.5.1 Dickinson and Company Company Information
11.5.2 Dickinson and Company Overview
11.5.3 Dickinson and Company 3D Hydrogels in Cell Culture Sales, Price, Revenue and Gross Margin (2018-2023)
11.5.4 Dickinson and Company 3D Hydrogels in Cell Culture Product Model Numbers, Pictures, Descriptions and Specifications
11.5.5 Dickinson and Company Recent Developments
11.6 Corning
11.6.1 Corning Company Information
11.6.2 Corning Overview
11.6.3 Corning 3D Hydrogels in Cell Culture Sales, Price, Revenue and Gross Margin (2018-2023)
11.6.4 Corning 3D Hydrogels in Cell Culture Product Model Numbers, Pictures, Descriptions and Specifications
11.6.5 Corning Recent Developments
11.7 Global Cell Solutions
11.7.1 Global Cell Solutions Company Information
11.7.2 Global Cell Solutions Overview
11.7.3 Global Cell Solutions 3D Hydrogels in Cell Culture Sales, Price, Revenue and Gross Margin (2018-2023)
11.7.4 Global Cell Solutions 3D Hydrogels in Cell Culture Product Model Numbers, Pictures, Descriptions and Specifications
11.7.5 Global Cell Solutions Recent Developments
11.8 InSphero
11.8.1 InSphero Company Information
11.8.2 InSphero Overview
11.8.3 InSphero 3D Hydrogels in Cell Culture Sales, Price, Revenue and Gross Margin (2018-2023)
11.8.4 InSphero 3D Hydrogels in Cell Culture Product Model Numbers, Pictures, Descriptions and Specifications
11.8.5 InSphero Recent Developments
11.9 Lonza Group
11.9.1 Lonza Group Company Information
11.9.2 Lonza Group Overview
11.9.3 Lonza Group 3D Hydrogels in Cell Culture Sales, Price, Revenue and Gross Margin (2018-2023)
11.9.4 Lonza Group 3D Hydrogels in Cell Culture Product Model Numbers, Pictures, Descriptions and Specifications
11.9.5 Lonza Group Recent Developments
11.10 Nanofiber Solutions
11.10.1 Nanofiber Solutions Company Information
11.10.2 Nanofiber Solutions Overview
11.10.3 Nanofiber Solutions 3D Hydrogels in Cell Culture Sales, Price, Revenue and Gross Margin (2018-2023)
11.10.4 Nanofiber Solutions 3D Hydrogels in Cell Culture Product Model Numbers, Pictures, Descriptions and Specifications
11.10.5 Nanofiber Solutions Recent Developments
11.11 Boca Scientific
11.11.1 Boca Scientific Company Information
11.11.2 Boca Scientific Overview
11.11.3 Boca Scientific 3D Hydrogels in Cell Culture Sales, Price, Revenue and Gross Margin (2018-2023)
11.11.4 Boca Scientific 3D Hydrogels in Cell Culture Product Model Numbers, Pictures, Descriptions and Specifications
11.11.5 Boca Scientific Recent Developments
11.12 Esi Bio
11.12.1 Esi Bio Company Information
11.12.2 Esi Bio Overview
11.12.3 Esi Bio 3D Hydrogels in Cell Culture Sales, Price, Revenue and Gross Margin (2018-2023)
11.12.4 Esi Bio 3D Hydrogels in Cell Culture Product Model Numbers, Pictures, Descriptions and Specifications
11.12.5 Esi Bio Recent Developments
11.13 Sigma-Aldrich Corp
11.13.1 Sigma-Aldrich Corp Company Information
11.13.2 Sigma-Aldrich Corp Overview
11.13.3 Sigma-Aldrich Corp 3D Hydrogels in Cell Culture Sales, Price, Revenue and Gross Margin (2018-2023)
11.13.4 Sigma-Aldrich Corp 3D Hydrogels in Cell Culture Product Model Numbers, Pictures, Descriptions and Specifications
11.13.5 Sigma-Aldrich Corp Recent Developments
11.14 Ferentis
11.14.1 Ferentis Company Information
11.14.2 Ferentis Overview
11.14.3 Ferentis 3D Hydrogels in Cell Culture Sales, Price, Revenue and Gross Margin (2018-2023)
11.14.4 Ferentis 3D Hydrogels in Cell Culture Product Model Numbers, Pictures, Descriptions and Specifications
11.14.5 Ferentis Recent Developments
11.15 Tecan Trading
11.15.1 Tecan Trading Company Information
11.15.2 Tecan Trading Overview
11.15.3 Tecan Trading 3D Hydrogels in Cell Culture Sales, Price, Revenue and Gross Margin (2018-2023)
11.15.4 Tecan Trading 3D Hydrogels in Cell Culture Product Model Numbers, Pictures, Descriptions and Specifications
11.15.5 Tecan Trading Recent Developments
11.16 Cellendes
11.16.1 Cellendes Company Information
11.16.2 Cellendes Overview
11.16.3 Cellendes 3D Hydrogels in Cell Culture Sales, Price, Revenue and Gross Margin (2018-2023)
11.16.4 Cellendes 3D Hydrogels in Cell Culture Product Model Numbers, Pictures, Descriptions and Specifications
11.16.5 Cellendes Recent Developments
11.17 Cosmo Bio USA
11.17.1 Cosmo Bio USA Company Information
11.17.2 Cosmo Bio USA Overview
11.17.3 Cosmo Bio USA 3D Hydrogels in Cell Culture Sales, Price, Revenue and Gross Margin (2018-2023)
11.17.4 Cosmo Bio USA 3D Hydrogels in Cell Culture Product Model Numbers, Pictures, Descriptions and Specifications
11.17.5 Cosmo Bio USA Recent Developments
11.18 Thermo Fisher Scientific
11.18.1 Thermo Fisher Scientific Company Information
11.18.2 Thermo Fisher Scientific Overview
11.18.3 Thermo Fisher Scientific 3D Hydrogels in Cell Culture Sales, Price, Revenue and Gross Margin (2018-2023)
11.18.4 Thermo Fisher Scientific 3D Hydrogels in Cell Culture Product Model Numbers, Pictures, Descriptions and Specifications
11.18.5 Thermo Fisher Scientific Recent Developments
12 INDUSTRY CHAIN AND SALES CHANNELS ANALYSIS
12.1 3D Hydrogels in Cell Culture Industry Chain Analysis
12.2 3D Hydrogels in Cell Culture Key Raw Materials
12.2.1 Key Raw Materials
12.2.2 Raw Materials Key Suppliers
12.3 3D Hydrogels in Cell Culture Production Mode & Process
12.4 3D Hydrogels in Cell Culture Sales and Marketing
12.4.1 3D Hydrogels in Cell Culture Sales Channels
12.4.2 3D Hydrogels in Cell Culture Distributors
12.5 3D Hydrogels in Cell Culture Customers
13 MARKET DYNAMICS
13.1 3D Hydrogels in Cell Culture Industry Trends
13.2 3D Hydrogels in Cell Culture Market Drivers
13.3 3D Hydrogels in Cell Culture Market Challenges
13.4 3D Hydrogels in Cell Culture Market Restraints
14 KEY FINDINGS IN THE GLOBAL 3D HYDROGELS IN CELL CULTURE STUDY
15 APPENDIX
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Author Details
15.3 Disclaimer
LIST OF TABLES
Table 1. Global Complement Drug Market Size Growth Rate by Type (US$ Million): 2018 VS 2022 VS 2029
Table 2. Key Players of Peptides
Table 3. Key Players of Antibodies
Table 4. Key Players of Others
Table 5. Global Complement Drug Market Size Growth by Application (US$ Million): 2018 VS 2022 VS 2029
Table 6. Global Complement Drug Market Size by Region (US$ Million): 2018 VS 2022 VS 2029
Table 7. Global Complement Drug Market Size by Region (2018-2023) & (US$ Million)
Table 8. Global Complement Drug Market Share by Region (2018-2023)
Table 9. Global Complement Drug Forecasted Market Size by Region (2024-2029) & (US$ Million)
Table 10. Global Complement Drug Market Share by Region (2024-2029)
Table 11. Complement Drug Market Trends
Table 12. Complement Drug Market Drivers
Table 13. Complement Drug Market Challenges
Table 14. Complement Drug Market Restraints
Table 15. Global Complement Drug Revenue by Players (2018-2023) & (US$ Million)
Table 16. Global Complement Drug Market Share by Players (2018-2023)
Table 17. Global Top Complement Drug Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Complement Drug as of 2022)
Table 18. Ranking of Global Top Complement Drug Companies by Revenue (US$ Million) in 2022
Table 19. Global 5 Largest Players Market Share by Complement Drug Revenue (CR5 and HHI) & (2018-2023)
Table 20. Key Players Headquarters and Area Served
Table 21. Key Players Complement Drug Product Solution and Service
Table 22. Date of Enter into Complement Drug Market
Table 23. Mergers & Acquisitions, Expansion Plans
Table 24. Global Complement Drug Market Size by Type (2018-2023) & (US$ Million)
Table 25. Global Complement Drug Revenue Market Share by Type (2018-2023)
Table 26. Global Complement Drug Forecasted Market Size by Type (2024-2029) & (US$ Million)
Table 27. Global Complement Drug Revenue Market Share by Type (2024-2029)
Table 28. Global Complement Drug Market Size by Application (2018-2023) & (US$ Million)
Table 29. Global Complement Drug Revenue Market Share by Application (2018-2023)
Table 30. Global Complement Drug Forecasted Market Size by Application (2024-2029) & (US$ Million)
Table 31. Global Complement Drug Revenue Market Share by Application (2024-2029)
Table 32. North America Complement Drug Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029
Table 33. North America Complement Drug Market Size by Country (2018-2023) & (US$ Million)
Table 34. North America Complement Drug Market Size by Country (2024-2029) & (US$ Million)
Table 35. Europe Complement Drug Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029
Table 36. Europe Complement Drug Market Size by Country (2018-2023) & (US$ Million)
Table 37. Europe Complement Drug Market Size by Country (2024-2029) & (US$ Million)
Table 38. Asia-Pacific Complement Drug Market Size Growth Rate by Region (US$ Million): 2018 VS 2022 VS 2029
Table 39. Asia-Pacific Complement Drug Market Size by Region (2018-2023) & (US$ Million)
Table 40. Asia-Pacific Complement Drug Market Size by Region (2024-2029) & (US$ Million)
Table 41. Latin America Complement Drug Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029
Table 42. Latin America Complement Drug Market Size by Country (2018-2023) & (US$ Million)
Table 43. Latin America Complement Drug Market Size by Country (2024-2029) & (US$ Million)
Table 44. Middle East & Africa Complement Drug Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029
Table 45. Middle East & Africa Complement Drug Market Size by Country (2018-2023) & (US$ Million)
Table 46. Middle East & Africa Complement Drug Market Size by Country (2024-2029) & (US$ Million)
Table 47. Novartis AG Company Detail
Table 48. Novartis AG Business Overview
Table 49. Novartis AG Complement Drug Product
Table 50. Novartis AG Revenue in Complement Drug Business (2018-2023) & (US$ Million)
Table 51. Novartis AG Recent Development
Table 52. Alexion Pharmaceuticals Company Detail
Table 53. Alexion Pharmaceuticals Business Overview
Table 54. Alexion Pharmaceuticals Complement Drug Product
Table 55. Alexion Pharmaceuticals Revenue in Complement Drug Business (2018-2023) & (US$ Million)
Table 56. Alexion Pharmaceuticals Recent Development
Table 57. ChemoCentryx Company Detail
Table 58. ChemoCentryx Business Overview
Table 59. ChemoCentryx Complement Drug Product
Table 60. ChemoCentryx Revenue in Complement Drug Business (2018-2023) & (US$ Million)
Table 61. ChemoCentryx Recent Development
Table 62. Roche Company Detail
Table 63. Roche Business Overview
Table 64. Roche Complement Drug Product
Table 65. Roche Revenue in Complement Drug Business (2018-2023) & (US$ Million)
Table 66. Roche Recent Development
Table 67. Apellis Company Detail
Table 68. Apellis Business Overview
Table 69. Apellis Complement Drug Product
Table 70. Apellis Revenue in Complement Drug Business (2018-2023) & (US$ Million)
Table 71. Apellis Recent Development
Table 72. Regeneron Company Detail
Table 73. Regeneron Business Overview
Table 74. Regeneron Complement Drug Product
Table 75. Regeneron Revenue in Complement Drug Business (2018-2023) & (US$ Million)
Table 76. Regeneron Recent Development
Table 77. Amgen Company Detail
Table 78. Amgen Business Overview
Table 79. Amgen Complement Drug Product
Table 80. Amgen Revenue in Complement Drug Business (2018-2023) & (US$ Million)
Table 81. Amgen Recent Development
Table 82. Alnylam Company Detail
Table 83. Alnylam Business Overview
Table 84. Alnylam Complement Drug Product
Table 85. Alnylam Revenue in Complement Drug Business (2018-2023) & (US$ Million)
Table 86. Alnylam Recent Development
Table 87. UCB Company Detail
Table 88. UCB Business Overview
Table 89. UCB Complement Drug Product
Table 90. UCB Revenue in Complement Drug Business (2018-2023) & (US$ Million)
Table 91. UCB Recent Development
Table 92. InflaRx Company Detail
Table 93. InflaRx Business Overview
Table 94. InflaRx Complement Drug Product
Table 95. InflaRx Revenue in Complement Drug Business (2018-2023) & (US$ Million)
Table 96. InflaRx Recent Development
Table 97. ChemoCentryx Company Detail
Table 98. ChemoCentryx Business Overview
Table 99. ChemoCentryx Complement Drug Product
Table 100. ChemoCentryx Revenue in Complement Drug Business (2018-2023) & (US$ Million)
Table 101. ChemoCentryx Recent Development
Table 102. Innate Pharma Company Detail
Table 103. Innate Pharma Business Overview
Table 104. Innate Pharma Complement Drug Product
Table 105. Innate Pharma Revenue in Complement Drug Business (2018-2023) & (US$ Million)
Table 106. Innate Pharma Recent Development
Table 107. Ionis Pharmaceuticals Company Detail
Table 108. Ionis Pharmaceuticals Business Overview
Table 109. Ionis Pharmaceuticals Complement Drug Product
Table 110. Ionis Pharmaceuticals Revenue in Complement Drug Business (2018-2023) & (US$ Million)
Table 111. Ionis Pharmaceuticals Recent Development
Table 112. Avant Immunotherapeutics Company Detail
Table 113. Avant Immunotherapeutics Business Overview
Table 114. Avant Immunotherapeutics Complement Drug Product
Table 115. Avant Immunotherapeutics Revenue in Complement Drug Business (2018-2023) & (US$ Million)
Table 116. Avant Immunotherapeutics Recent Development
Table 117. Pfizer Company Detail
Table 118. Pfizer Business Overview
Table 119. Pfizer Complement Drug Product
Table 120. Pfizer Revenue in Complement Drug Business (2018-2023) & (US$ Million)
Table 121. Pfizer Recent Development
Table 122. Sanofi Company Detail
Table 123. Sanofi Business Overview
Table 124. Sanofi Complement Drug Product
Table 125. Sanofi Revenue in Complement Drug Business (2018-2023) & (US$ Million)
Table 126. Sanofi Recent Development
Table 127. Omeros Company Detail
Table 128. Omeros Business Overview
Table 129. Omeros Complement Drug Product
Table 130. Omeros Revenue in Complement Drug Business (2018-2023) & (US$ Million)
Table 131. Omeros Recent Development
Table 132. GenMab Company Detail
Table 133. GenMab Business Overview
Table 134. GenMab Complement Drug Product
Table 135. GenMab Revenue in Complement Drug Business (2018-2023) & (US$ Million)
Table 136. GenMab Recent Development
Table 137. Akari Therapeutics Company Detail
Table 138. Akari Therapeutics Business Overview
Table 139. Akari Therapeutics Complement Drug Product
Table 140. Akari Therapeutics Revenue in Complement Drug Business (2018-2023) & (US$ Million)
Table 141. Akari Therapeutics Recent Development
Table 142. AbbVie Company Detail
Table 143. AbbVie Business Overview
Table 144. AbbVie Complement Drug Product
Table 145. AbbVie Revenue in Complement Drug Business (2018-2023) & (US$ Million)
Table 146. AbbVie Recent Development
Table 147. Research Programs/Design for This Report
Table 148. Key Data Information from Secondary Sources
Table 149. Key Data Information from Primary Sources
Table 1. Global Complement Drug Market Size Growth Rate by Type (US$ Million): 2018 VS 2022 VS 2029
Table 2. Key Players of Peptides
Table 3. Key Players of Antibodies
Table 4. Key Players of Others
Table 5. Global Complement Drug Market Size Growth by Application (US$ Million): 2018 VS 2022 VS 2029
Table 6. Global Complement Drug Market Size by Region (US$ Million): 2018 VS 2022 VS 2029
Table 7. Global Complement Drug Market Size by Region (2018-2023) & (US$ Million)
Table 8. Global Complement Drug Market Share by Region (2018-2023)
Table 9. Global Complement Drug Forecasted Market Size by Region (2024-2029) & (US$ Million)
Table 10. Global Complement Drug Market Share by Region (2024-2029)
Table 11. Complement Drug Market Trends
Table 12. Complement Drug Market Drivers
Table 13. Complement Drug Market Challenges
Table 14. Complement Drug Market Restraints
Table 15. Global Complement Drug Revenue by Players (2018-2023) & (US$ Million)
Table 16. Global Complement Drug Market Share by Players (2018-2023)
Table 17. Global Top Complement Drug Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Complement Drug as of 2022)
Table 18. Ranking of Global Top Complement Drug Companies by Revenue (US$ Million) in 2022
Table 19. Global 5 Largest Players Market Share by Complement Drug Revenue (CR5 and HHI) & (2018-2023)
Table 20. Key Players Headquarters and Area Served
Table 21. Key Players Complement Drug Product Solution and Service
Table 22. Date of Enter into Complement Drug Market
Table 23. Mergers & Acquisitions, Expansion Plans
Table 24. Global Complement Drug Market Size by Type (2018-2023) & (US$ Million)
Table 25. Global Complement Drug Revenue Market Share by Type (2018-2023)
Table 26. Global Complement Drug Forecasted Market Size by Type (2024-2029) & (US$ Million)
Table 27. Global Complement Drug Revenue Market Share by Type (2024-2029)
Table 28. Global Complement Drug Market Size by Application (2018-2023) & (US$ Million)
Table 29. Global Complement Drug Revenue Market Share by Application (2018-2023)
Table 30. Global Complement Drug Forecasted Market Size by Application (2024-2029) & (US$ Million)
Table 31. Global Complement Drug Revenue Market Share by Application (2024-2029)
Table 32. North America Complement Drug Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029
Table 33. North America Complement Drug Market Size by Country (2018-2023) & (US$ Million)
Table 34. North America Complement Drug Market Size by Country (2024-2029) & (US$ Million)
Table 35. Europe Complement Drug Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029
Table 36. Europe Complement Drug Market Size by Country (2018-2023) & (US$ Million)
Table 37. Europe Complement Drug Market Size by Country (2024-2029) & (US$ Million)
Table 38. Asia-Pacific Complement Drug Market Size Growth Rate by Region (US$ Million): 2018 VS 2022 VS 2029
Table 39. Asia-Pacific Complement Drug Market Size by Region (2018-2023) & (US$ Million)
Table 40. Asia-Pacific Complement Drug Market Size by Region (2024-2029) & (US$ Million)
Table 41. Latin America Complement Drug Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029
Table 42. Latin America Complement Drug Market Size by Country (2018-2023) & (US$ Million)
Table 43. Latin America Complement Drug Market Size by Country (2024-2029) & (US$ Million)
Table 44. Middle East & Africa Complement Drug Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029
Table 45. Middle East & Africa Complement Drug Market Size by Country (2018-2023) & (US$ Million)
Table 46. Middle East & Africa Complement Drug Market Size by Country (2024-2029) & (US$ Million)
Table 47. Novartis AG Company Detail
Table 48. Novartis AG Business Overview
Table 49. Novartis AG Complement Drug Product
Table 50. Novartis AG Revenue in Complement Drug Business (2018-2023) & (US$ Million)
Table 51. Novartis AG Recent Development
Table 52. Alexion Pharmaceuticals Company Detail
Table 53. Alexion Pharmaceuticals Business Overview
Table 54. Alexion Pharmaceuticals Complement Drug Product
Table 55. Alexion Pharmaceuticals Revenue in Complement Drug Business (2018-2023) & (US$ Million)
Table 56. Alexion Pharmaceuticals Recent Development
Table 57. ChemoCentryx Company Detail
Table 58. ChemoCentryx Business Overview
Table 59. ChemoCentryx Complement Drug Product
Table 60. ChemoCentryx Revenue in Complement Drug Business (2018-2023) & (US$ Million)
Table 61. ChemoCentryx Recent Development
Table 62. Roche Company Detail
Table 63. Roche Business Overview
Table 64. Roche Complement Drug Product
Table 65. Roche Revenue in Complement Drug Business (2018-2023) & (US$ Million)
Table 66. Roche Recent Development
Table 67. Apellis Company Detail
Table 68. Apellis Business Overview
Table 69. Apellis Complement Drug Product
Table 70. Apellis Revenue in Complement Drug Business (2018-2023) & (US$ Million)
Table 71. Apellis Recent Development
Table 72. Regeneron Company Detail
Table 73. Regeneron Business Overview
Table 74. Regeneron Complement Drug Product
Table 75. Regeneron Revenue in Complement Drug Business (2018-2023) & (US$ Million)
Table 76. Regeneron Recent Development
Table 77. Amgen Company Detail
Table 78. Amgen Business Overview
Table 79. Amgen Complement Drug Product
Table 80. Amgen Revenue in Complement Drug Business (2018-2023) & (US$ Million)
Table 81. Amgen Recent Development
Table 82. Alnylam Company Detail
Table 83. Alnylam Business Overview
Table 84. Alnylam Complement Drug Product
Table 85. Alnylam Revenue in Complement Drug Business (2018-2023) & (US$ Million)
Table 86. Alnylam Recent Development
Table 87. UCB Company Detail
Table 88. UCB Business Overview
Table 89. UCB Complement Drug Product
Table 90. UCB Revenue in Complement Drug Business (2018-2023) & (US$ Million)
Table 91. UCB Recent Development
Table 92. InflaRx Company Detail
Table 93. InflaRx Business Overview
Table 94. InflaRx Complement Drug Product
Table 95. InflaRx Revenue in Complement Drug Business (2018-2023) & (US$ Million)
Table 96. InflaRx Recent Development
Table 97. ChemoCentryx Company Detail
Table 98. ChemoCentryx Business Overview
Table 99. ChemoCentryx Complement Drug Product
Table 100. ChemoCentryx Revenue in Complement Drug Business (2018-2023) & (US$ Million)
Table 101. ChemoCentryx Recent Development
Table 102. Innate Pharma Company Detail
Table 103. Innate Pharma Business Overview
Table 104. Innate Pharma Complement Drug Product
Table 105. Innate Pharma Revenue in Complement Drug Business (2018-2023) & (US$ Million)
Table 106. Innate Pharma Recent Development
Table 107. Ionis Pharmaceuticals Company Detail
Table 108. Ionis Pharmaceuticals Business Overview
Table 109. Ionis Pharmaceuticals Complement Drug Product
Table 110. Ionis Pharmaceuticals Revenue in Complement Drug Business (2018-2023) & (US$ Million)
Table 111. Ionis Pharmaceuticals Recent Development
Table 112. Avant Immunotherapeutics Company Detail
Table 113. Avant Immunotherapeutics Business Overview
Table 114. Avant Immunotherapeutics Complement Drug Product
Table 115. Avant Immunotherapeutics Revenue in Complement Drug Business (2018-2023) & (US$ Million)
Table 116. Avant Immunotherapeutics Recent Development
Table 117. Pfizer Company Detail
Table 118. Pfizer Business Overview
Table 119. Pfizer Complement Drug Product
Table 120. Pfizer Revenue in Complement Drug Business (2018-2023) & (US$ Million)
Table 121. Pfizer Recent Development
Table 122. Sanofi Company Detail
Table 123. Sanofi Business Overview
Table 124. Sanofi Complement Drug Product
Table 125. Sanofi Revenue in Complement Drug Business (2018-2023) & (US$ Million)
Table 126. Sanofi Recent Development
Table 127. Omeros Company Detail
Table 128. Omeros Business Overview
Table 129. Omeros Complement Drug Product
Table 130. Omeros Revenue in Complement Drug Business (2018-2023) & (US$ Million)
Table 131. Omeros Recent Development
Table 132. GenMab Company Detail
Table 133. GenMab Business Overview
Table 134. GenMab Complement Drug Product
Table 135. GenMab Revenue in Complement Drug Business (2018-2023) & (US$ Million)
Table 136. GenMab Recent Development
Table 137. Akari Therapeutics Company Detail
Table 138. Akari Therapeutics Business Overview
Table 139. Akari Therapeutics Complement Drug Product
Table 140. Akari Therapeutics Revenue in Complement Drug Business (2018-2023) & (US$ Million)
Table 141. Akari Therapeutics Recent Development
Table 142. AbbVie Company Detail
Table 143. AbbVie Business Overview
Table 144. AbbVie Complement Drug Product
Table 145. AbbVie Revenue in Complement Drug Business (2018-2023) & (US$ Million)
Table 146. AbbVie Recent Development
Table 147. Research Programs/Design for This Report
Table 148. Key Data Information from Secondary Sources
Table 149. Key Data Information from Primary Sources
LIST OF FIGURES
Figure 1. Global Complement Drug Market Size Comparison by Type (2023-2029) & (US$ Million)
Figure 2. Global Complement Drug Market Share by Type: 2022 VS 2029
Figure 3. Peptides Features
Figure 4. Antibodies Features
Figure 5. Others Features
Figure 6. Global Complement Drug Market Size Comparison by Application (2023-2029) & (US$ Million)
Figure 7. Global Complement Drug Market Share by Application: 2022 VS 2029
Figure 8. Blood Disease Case Studies
Figure 9. Kidney Disease Case Studies
Figure 10. Others Case Studies
Figure 11. Complement Drug Report Years Considered
Figure 12. Global Complement Drug Market Size (US$ Million), Year-over-Year: 2018-2029
Figure 13. Global Complement Drug Market Size, (US$ Million), 2018 VS 2022 VS 2029
Figure 14. Global Complement Drug Market Share by Region: 2022 VS 2029
Figure 15. Global Complement Drug Market Share by Players in 2022
Figure 16. Global Top Complement Drug Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Complement Drug as of 2022)
Figure 17. The Top 10 and 5 Players Market Share by Complement Drug Revenue in 2022
Figure 18. North America Complement Drug Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 19. North America Complement Drug Market Share by Country (2018-2029)
Figure 20. United States Complement Drug Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 21. Canada Complement Drug Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 22. Europe Complement Drug Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 23. Europe Complement Drug Market Share by Country (2018-2029)
Figure 24. Germany Complement Drug Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 25. France Complement Drug Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 26. U.K. Complement Drug Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 27. Italy Complement Drug Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 28. Russia Complement Drug Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 29. Nordic Countries Complement Drug Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 30. Asia-Pacific Complement Drug Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 31. Asia-Pacific Complement Drug Market Share by Region (2018-2029)
Figure 32. China Complement Drug Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 33. Japan Complement Drug Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 34. South Korea Complement Drug Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 35. Southeast Asia Complement Drug Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 36. India Complement Drug Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 37. Australia Complement Drug Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 38. Latin America Complement Drug Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 39. Latin America Complement Drug Market Share by Country (2018-2029)
Figure 40. Mexico Complement Drug Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 41. Brazil Complement Drug Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 42. Middle East & Africa Complement Drug Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 43. Middle East & Africa Complement Drug Market Share by Country (2018-2029)
Figure 44. Turkey Complement Drug Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 45. Saudi Arabia Complement Drug Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 46. Novartis AG Revenue Growth Rate in Complement Drug Business (2018-2023)
Figure 47. Alexion Pharmaceuticals Revenue Growth Rate in Complement Drug Business (2018-2023)
Figure 48. ChemoCentryx Revenue Growth Rate in Complement Drug Business (2018-2023)
Figure 49. Roche Revenue Growth Rate in Complement Drug Business (2018-2023)
Figure 50. Apellis Revenue Growth Rate in Complement Drug Business (2018-2023)
Figure 51. Regeneron Revenue Growth Rate in Complement Drug Business (2018-2023)
Figure 52. Amgen Revenue Growth Rate in Complement Drug Business (2018-2023)
Figure 53. Alnylam Revenue Growth Rate in Complement Drug Business (2018-2023)
Figure 54. UCB Revenue Growth Rate in Complement Drug Business (2018-2023)
Figure 55. InflaRx Revenue Growth Rate in Complement Drug Business (2018-2023)
Figure 56. ChemoCentryx Revenue Growth Rate in Complement Drug Business (2018-2023)
Figure 57. Innate Pharma Revenue Growth Rate in Complement Drug Business (2018-2023)
Figure 58. Ionis Pharmaceuticals Revenue Growth Rate in Complement Drug Business (2018-2023)
Figure 59. Avant Immunotherapeutics Revenue Growth Rate in Complement Drug Business (2018-2023)
Figure 60. Pfizer Revenue Growth Rate in Complement Drug Business (2018-2023)
Figure 61. Sanofi Revenue Growth Rate in Complement Drug Business (2018-2023)
Figure 62. Omeros Revenue Growth Rate in Complement Drug Business (2018-2023)
Figure 63. GenMab Revenue Growth Rate in Complement Drug Business (2018-2023)
Figure 64. Akari Therapeutics Revenue Growth Rate in Complement Drug Business (2018-2023)
Figure 65. AbbVie Revenue Growth Rate in Complement Drug Business (2018-2023)
Figure 66. Bottom-up and Top-down Approaches for This Report
Figure 67. Data Triangulation
Figure 68. Key Executives Interviewed
Figure 1. Global Complement Drug Market Size Comparison by Type (2023-2029) & (US$ Million)
Figure 2. Global Complement Drug Market Share by Type: 2022 VS 2029
Figure 3. Peptides Features
Figure 4. Antibodies Features
Figure 5. Others Features
Figure 6. Global Complement Drug Market Size Comparison by Application (2023-2029) & (US$ Million)
Figure 7. Global Complement Drug Market Share by Application: 2022 VS 2029
Figure 8. Blood Disease Case Studies
Figure 9. Kidney Disease Case Studies
Figure 10. Others Case Studies
Figure 11. Complement Drug Report Years Considered
Figure 12. Global Complement Drug Market Size (US$ Million), Year-over-Year: 2018-2029
Figure 13. Global Complement Drug Market Size, (US$ Million), 2018 VS 2022 VS 2029
Figure 14. Global Complement Drug Market Share by Region: 2022 VS 2029
Figure 15. Global Complement Drug Market Share by Players in 2022
Figure 16. Global Top Complement Drug Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Complement Drug as of 2022)
Figure 17. The Top 10 and 5 Players Market Share by Complement Drug Revenue in 2022
Figure 18. North America Complement Drug Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 19. North America Complement Drug Market Share by Country (2018-2029)
Figure 20. United States Complement Drug Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 21. Canada Complement Drug Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 22. Europe Complement Drug Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 23. Europe Complement Drug Market Share by Country (2018-2029)
Figure 24. Germany Complement Drug Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 25. France Complement Drug Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 26. U.K. Complement Drug Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 27. Italy Complement Drug Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 28. Russia Complement Drug Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 29. Nordic Countries Complement Drug Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 30. Asia-Pacific Complement Drug Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 31. Asia-Pacific Complement Drug Market Share by Region (2018-2029)
Figure 32. China Complement Drug Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 33. Japan Complement Drug Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 34. South Korea Complement Drug Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 35. Southeast Asia Complement Drug Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 36. India Complement Drug Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 37. Australia Complement Drug Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 38. Latin America Complement Drug Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 39. Latin America Complement Drug Market Share by Country (2018-2029)
Figure 40. Mexico Complement Drug Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 41. Brazil Complement Drug Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 42. Middle East & Africa Complement Drug Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 43. Middle East & Africa Complement Drug Market Share by Country (2018-2029)
Figure 44. Turkey Complement Drug Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 45. Saudi Arabia Complement Drug Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 46. Novartis AG Revenue Growth Rate in Complement Drug Business (2018-2023)
Figure 47. Alexion Pharmaceuticals Revenue Growth Rate in Complement Drug Business (2018-2023)
Figure 48. ChemoCentryx Revenue Growth Rate in Complement Drug Business (2018-2023)
Figure 49. Roche Revenue Growth Rate in Complement Drug Business (2018-2023)
Figure 50. Apellis Revenue Growth Rate in Complement Drug Business (2018-2023)
Figure 51. Regeneron Revenue Growth Rate in Complement Drug Business (2018-2023)
Figure 52. Amgen Revenue Growth Rate in Complement Drug Business (2018-2023)
Figure 53. Alnylam Revenue Growth Rate in Complement Drug Business (2018-2023)
Figure 54. UCB Revenue Growth Rate in Complement Drug Business (2018-2023)
Figure 55. InflaRx Revenue Growth Rate in Complement Drug Business (2018-2023)
Figure 56. ChemoCentryx Revenue Growth Rate in Complement Drug Business (2018-2023)
Figure 57. Innate Pharma Revenue Growth Rate in Complement Drug Business (2018-2023)
Figure 58. Ionis Pharmaceuticals Revenue Growth Rate in Complement Drug Business (2018-2023)
Figure 59. Avant Immunotherapeutics Revenue Growth Rate in Complement Drug Business (2018-2023)
Figure 60. Pfizer Revenue Growth Rate in Complement Drug Business (2018-2023)
Figure 61. Sanofi Revenue Growth Rate in Complement Drug Business (2018-2023)
Figure 62. Omeros Revenue Growth Rate in Complement Drug Business (2018-2023)
Figure 63. GenMab Revenue Growth Rate in Complement Drug Business (2018-2023)
Figure 64. Akari Therapeutics Revenue Growth Rate in Complement Drug Business (2018-2023)
Figure 65. AbbVie Revenue Growth Rate in Complement Drug Business (2018-2023)
Figure 66. Bottom-up and Top-down Approaches for This Report
Figure 67. Data Triangulation
Figure 68. Key Executives Interviewed
